Retatrutide Dual-Chamber Pen: OEM Manufacturing
ShiLai™ Healthcare manufactures Retatrutide dual-chamber injection pen systems for OEM and private label programs. The dual-chamber design keeps the lyophilized peptide and diluent separated until point of use, enabling reconstitution immediately before administration.
Dual-Chamber vs. Prefilled Pen
A dual-chamber pen system contains the lyophilized Retatrutide in one chamber and the diluent in a second chamber. Reconstitution occurs when the chambers are combined at point of use. This design provides superior stability compared to pre-mixed liquid formulations and is well-suited for peptides with limited solution stability.
OEM Dual-Chamber Pen Configuration
ShiLai™ Healthcare supports custom dual-chamber pen configurations including cartridge volume, concentration, pen device selection, and packaging design. OEM programs can be developed from concept through finished product with full analytical documentation.
Analytical Verification
Each batch of Retatrutide dual-chamber pen systems is supported by HPLC purity testing, LC-MS identity confirmation, and a Certificate of Analysis (COA).
Frequently Asked Questions
What is a dual-chamber Retatrutide pen?
A dual-chamber Retatrutide pen is an injection device with two separate compartments — one containing lyophilized Retatrutide and one containing diluent. The chambers are combined at point of use to reconstitute the peptide before injection.
Why use a dual-chamber pen for Retatrutide?
The dual-chamber design keeps the peptide in lyophilized form until use, providing better stability than pre-mixed liquid formulations. This is particularly important for peptides that may degrade in solution over time.